Cadila Pharmaceuticals Limited — Isoniazid Exporter Profile
Indian Pharmaceutical Exporter · #12 for Isoniazid · $783.6K export value · DGFT Verified
Cadila Pharmaceuticals Limited is the #12 Indian exporter of Isoniazid with $783.6K in export value and 32 verified shipments. Cadila Pharmaceuticals Limited holds a 0.0% market share in Isoniazid exports across 12 countries. The company exports 15 pharmaceutical products worth $20.2M across 11 therapeutic categories.
Cadila Pharmaceuticals Limited — Isoniazid Export Profile: Buyers & Destinations
Where Does Cadila Pharmaceuticals Limited Export Isoniazid?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MOZAMBIQUE | $161.0K | 6 | 29.8% |
| CAMEROON | $132.0K | 3 | 24.4% |
| AUSTRALIA | $77.8K | 12 | 14.4% |
| KENYA | $50.0K | 1 | 9.3% |
| HAITI | $49.0K | 1 | 9.1% |
| NETHERLANDS | $29.9K | 3 | 5.5% |
| INDONESIA | $17.0K | 1 | 3.1% |
| SIERRA LEONE | $16.2K | 1 | 3.0% |
| PARAGUAY | $3.2K | 1 | 0.6% |
| HONDURAS | $2.6K | 1 | 0.5% |
Cadila Pharmaceuticals Limited exports Isoniazid to 12 countries. The largest destination is MOZAMBIQUE accounting for 29.8% of Cadila Pharmaceuticals Limited's Isoniazid shipments, followed by CAMEROON (24.4%) and AUSTRALIA (14.4%). These destinations reflect Cadila Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Isoniazid from Cadila Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CENTRAL DE MEDICAMENTOS E ARTIGOS | MOZAMBIQUE | $150.0K | 3 |
| CENAME | CAMEROON | $132.0K | 3 |
| ARROW PHARMACEUTICALS PTY LTD. | AUSTRALIA | $55.5K | 8 |
| KENYA MEDICAL SUPPLIES AGENCY | KENYA | $50.0K | 1 |
| USAID HAITI | HAITI | $49.0K | 1 |
| ARROW PHARMACEUTICALS PTY LTD | AUSTRALIA | $22.3K | 4 |
| SEKRETARIAT DITJEN PENCEGAHAN DAN | INDONESIA | $17.0K | 1 |
| MINISTRY OF HEALTH AND SANITATION | SIERRA LEONE | $16.2K | 1 |
| GDF TILLBURG SRS D102TC | NETHERLANDS | $15.1K | 1 |
| GDF TILBURG SRS D102TC | NETHERLANDS | $14.8K | 2 |
Cadila Pharmaceuticals Limited supplies Isoniazid to 15 buyers globally. The largest buyer is CENTRAL DE MEDICAMENTOS E ARTIGOS (MOZAMBIQUE), followed by CENAME (CAMEROON) and ARROW PHARMACEUTICALS PTY LTD. (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Isoniazid Export Value and How Much Does Cadila Pharmaceuticals Limited Contribute?
India exported $159.1M worth of Isoniazid through 3,835 shipments from 127 suppliers to 163 countries, serving 829 buyers globally. Cadila Pharmaceuticals Limited contributes $783.6K to this total, accounting for 0.0% of India's Isoniazid exports. Cadila Pharmaceuticals Limited ships Isoniazid to 12 countries through 15 buyers.
What Is the Average Shipment Value for Cadila Pharmaceuticals Limited's Isoniazid Exports?
Cadila Pharmaceuticals Limited's average Isoniazid shipment value is $24.5K per consignment, based on 32 shipments totaling $783.6K. The largest destination is MOZAMBIQUE (29.8% of Cadila Pharmaceuticals Limited's Isoniazid exports).
How Does Cadila Pharmaceuticals Limited Compare to Other Indian Isoniazid Exporters?
Cadila Pharmaceuticals Limited ranks #12 among 127 Indian Isoniazid exporters with a 0.0% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($69.5M), LUPIN LIMITED ($38.5M), MACLEODS PHARMACEUTICALS LIMITED ($23.9M). Cadila Pharmaceuticals Limited processed 32 shipments to 12 destination countries.
What Isoniazid Formulations Does Cadila Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICALS MEDICINES : ISONIAZID 300MG TABLET ISONIAZID BP (24 X 28 T) (24,465 PACK)NOS | $150.0K | 3 |
| PHARMACEUTICALS MEDICINES :ISONIAZID 300MG TABLET ISONIAZID BP. (24 X 28 T) (10,000 PACK) | $132.0K | 3 |
| ISONIAZID 300MG TABLETS ISONIAZID BP DETAILS AS PER INVOICE | $50.0K | 1 |
| ISONIAZID TABLETS BP 300MG (RAW MATERIAL | $49.0K | 1 |
| PHARMACEUTICALS MEDICINES- ISONIAZID 300 | $17.0K | 1 |
| PHARMACEUTICALS MEDICINES : ISONIAZID 300MG TABLET ISONIAZID BP 24 X 28 T 1203 PACK | $16.2K | 1 |
| ISONIAZID 300MG TABLET ISONIAZID BP | $15.1K | 1 |
| PHA DRG MED ISONIAZID 300MG TABLET CONT ISONIAZID BP QTY 672T PAC | $14.8K | 2 |
| ISONIAZID 100MG TABLET (RM:ISONIAZID E.P | $14.4K | 2 |
| ISONIAZID 100MG TABLET (R/M : ISONIAZID | $14.4K | 2 |
Cadila Pharmaceuticals Limited exports 18 distinct Isoniazid formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICALS MEDICINES : ISONIAZID 300MG TABLET ISONIAZID with 3 shipments worth $150.0K.
Regulatory Requirements: Exporting Isoniazid to Key Markets
What Cadila Pharmaceuticals Limited must comply with to export Isoniazid to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Cadila Pharmaceuticals Limited Compare to Nearest Isoniazid Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | MANEESH PHARMACEUTICALS LTD | $850.0K | 17 | 7 | $50.0K |
| 10 | RECIPHARM PHARMASERVICES PRIVATE LIMITED | $847.2K | 24 | 1 | $35.3K |
| 12 | CADILA PHARMACEUTICALS LIMITED ★ | $783.6K | 32 | 12 | $24.5K |
| 11 | UNILINK PHARMA PRIVATE LIMITED | $600.0K | 12 | 2 | $50.0K |
| 13 | MEDWISE OVERSEAS PRIVATE LIMITED | $356.8K | 17 | 3 | $21.0K |
Cadila Pharmaceuticals Limited ranks #12 among 127 Indian Isoniazid exporters. Average shipment value of $24.5K compared to the market average of $1.3M. The closest competitors by value are MANEESH PHARMACEUTICALS LTD and RECIPHARM PHARMASERVICES PRIVATE LIMITED.
Which Indian Ports Ship Isoniazid Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 813 | 21.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 796 | 20.8% |
| DELHI AIR | 393 | 10.2% |
| NHAVA SHEVA SEA (INNSA1) | 324 | 8.4% |
| DELHI AIR CARGO ACC (INDEL4) | 316 | 8.2% |
| JNPT/ NHAVA SHEVA SEA | 185 | 4.8% |
| Bombay Air | 163 | 4.3% |
| JNPT | 163 | 4.3% |
What Other Tuberculosis Medications Products Does Cadila Pharmaceuticals Limited Export?
Cadila Pharmaceuticals Limited also exports these tuberculosis medications products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Cadila Pharmaceuticals Limited's Isoniazid Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Cadila Pharmaceuticals. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, causing major carriers to suspend or reroute transits. This has resulted in extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes, impacting the timely delivery of pharmaceuticals. (livemint.com)
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. However, the U.S. has also implemented tariffs on Active Pharmaceutical Ingredients (APIs), leading to a reshoring of manufacturing and affecting Indian firms. In response, some Indian companies have invested in U.S. facilities to circumvent these tariffs. (odrindia.in)
In the European Union, compliance with the Falsified Medicines Directive (FMD) has become imperative. Indian exporters must ensure stringent adherence to these regulations to maintain market access, necessitating investments in serialization and traceability systems.
Cadila Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is crucial for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) has previously issued warnings to Cadila Pharmaceuticals regarding deviations from standard manufacturing practices. (business-standard.com) To address such concerns, the company has invested in enhancing its quality control systems and manufacturing processes. Additionally, Cadila has engaged in legal proceedings concerning biosimilar approvals, highlighting the complexities of regulatory compliance in the biosimilars market. (legaleraonline.com)
About Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited exports 15 products worth $20.2M. Beyond Isoniazid, top products include Mebendazole, Verapamil, Folic, Domperidone, Ethambutol. View the complete Cadila Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Isoniazid — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Isoniazid shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Cadila Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 32 individual customs records matching Cadila Pharmaceuticals Limited exporting Isoniazid, covering 18 formulations to 12 countries via 15 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 163+ countries, 829+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Isoniazid Export Data from Cadila Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cadila Pharmaceuticals Limited's Isoniazid exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Cadila Pharmaceuticals Limited
Full Company Profile →
15 products · $20.2M total trade · 11 categories
Isoniazid Stats
Company Overview
Top Products by Cadila Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Cadila Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Isoniazid. For current shipment-level data, contact TransData Nexus.